NEW YORK, Nov. 7, 2016 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of InfuSystems Holdings, Inc. (NYSEMKT: INFU) resulting from allegations that InfuSystems may have issued materially misleading business information to the investing public.
On November 7, 2016, InfuSystems filed a Form 8-K with the SEC revealing that "the Company's audited financial statements for the fiscal year ended December 31, 2015, and the Company's unaudited financial statements for each of the fiscal quarters ended March 31, 2015 through June 30, 2016 should no longer be relied upon", due to "an error related to an overstatement of estimated accounts receivable collections which in turn overstated revenues and pre-tax income by a corresponding amount." InfuSystems disclosed that it's "Audit Committee believes that material adjustments to the Financial Statements are required and that the Company will need to restate the Financial Statements." On this news, shares of InfuSystems fell $1.00 per share or over 38% to close at $1.60 per share on November 7, 2016. Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by InfuSystems investors. If you purchased shares of InfuSystems please visit the firm's website at http://www.rosenlegal.com/cases-987.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at email@example.com or firstname.lastname@example.org. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.